TCR-like bispecific antibodies toward eliminating infected hepatocytes in HBV mouse models

Both middle and large envelope proteins can mediate neutralization of hepatitis B virus infectivity by anti-preS2 antibodies: escape by naturally occurring preS2 deletions

Orchestrated Codelivery of Peptide Antigen and Adjuvant to Antigen-Presenting Cells by Using an Engineered Chimeric Peptide Enhances Antitumor T-Cell Immunity

Major HBV splice variant encoding a novel protein important for infection

Combination therapy with oncolytic virus and T cells or mRNA vaccine amplifies antitumor effects

Therapeutic vaccine-induced plasma cell differentiation is defective in the presence of persistently high HBsAg levels

Swine pseudorabies virus attenuated vaccine reprograms the kidney cancer tumor microenvironment and synergizes with PD-1 blockade

Light-Induced Mechanically Robust Hydrogel with Superelasticity and Fatigue Resistance for Bioprinting of Cell-Laden Architectures

A Dual-domain Engineered Antibody for Efficient HBV Suppression and Immune Responses Restoration

Evolution of the SARS-CoV-2 Omicron Variants: Genetic Impact on Viral Fitness

Micronanoparticled risedronate exhibits potent vaccine adjuvant effects

A glycoengineered therapeutic anti-HBV antibody that allows increased HBsAg immunoclearance improves HBV suppression <i>in vivo</i>

The potential of swine pseudorabies virus attenuated vaccine for oncolytic therapy against malignant tumors

Structural basis for broad neutralization of human antibody against Omicron sublineages and evasion by XBB variant

MAVI1, an endoplasmic reticulum-localized microprotein, suppresses antiviral innate immune response by targeting MAVS on mitochondrion

Evolving spike mutations in SARS-CoV-2 Omicron variants facilitate evasion from breakthrough infection-acquired antibodies

Effectiveness of first and second boost COVID-19 vaccination in healthy adults during BA.5.2/BF.7 surge in China

Two antibodies show broad, synergistic neutralization against SARS-CoV-2 variants by inducing conformational change within the RBD

Intranasal influenza-vectored COVID-19 vaccine restrains the SARS-CoV-2 inflammatory response in hamsters

Combination therapy of therapeutic antibody and vaccine or entecavir in HBV carrier mice

Hepatitis B Core Antibody Level: A Surrogate Marker for Host Antiviral Immunity in Chronic Hepatitis B Virus Infections

A Heterologous Challenge Rescues the Attenuated Immunogenicity of SARS-CoV-2 Omicron BA.1 Variant in Syrian Hamster Model

Antiviral Nanobiologic Therapy Remodulates Innate Immune Responses to Highly Pathogenic Coronavirus

A prophylactic effect of aluminium-based adjuvants against respiratory viruses via priming local innate immunity

Nasal irrigation efficiently attenuates SARS-CoV-2 Omicron infection, transmission and lung injury in the Syrian hamster model

Discovery of 5-((4-(pyridin-3-yl)pyrimidin-2-yl) amino)-1H-indole-2-carboxamide derivatives as novel anti-cancer agents targeting Nur77

Lineage-mosaic and mutation-patched spike proteins for broad-spectrum COVID-19 vaccine

The duration and breadth of antibody responses to 3-dose of inactivated COVID-19 vaccinations in healthy blood donors: An observational study

New discovery of high-affinity SARS-CoV-2 spike S2 protein binding peptide selected by PhIP-Seq

Infection, pathology and interferon treatment of the SARS-CoV-2 Omicron BA.1 variant in juvenile, adult and aged Syrian hamsters

Potential of conserved antigenic sites in development of universal SARS-like coronavirus vaccines

Receptor-binding domain-anchored peptides block binding of severe acute respiratory syndrome coronavirus 2 spike proteins with cell surface angiotensin-converting enzyme 2

Development of functional antibodies against influenza B virus by activation-induced cytidine deaminase in hybridoma cells

Development of functional antibodies against influenza B virus by activation-induced cytidine deaminase in hybridoma cells

Three SARS-CoV-2 antibodies provide broad and synergistic neutralization against variants of concern, including Omicron

PIKfyve inhibitors against SARS-CoV-2 and its variants including Omicron

Cross-species tropism and antigenic landscapes of SARS-CoV-2 variants

Risk of hepatocellular carcinoma in antiviral treatment-naive chronic hepatitis B patients treated with entecavir or tenofovir disoproxil fumarate: a network meta-analysis

5 ' preS1 Mutations To Prevent Large Envelope Protein Expression from Hepatitis B Virus Genotype A or Genotype D Markedly Increase Polymerase-Envelope Fusion Protein

A broad-spectrum nanobody targeting the C-terminus of the hepatitis B surface antigen for chronic hepatitis B infection therapy

Persisting lung pathogenesis and minimum residual virus in hamster after acute COVID-19

A cell-penetrating whole molecule antibody targeting intracellular HBx suppresses hepatitis B virus via TRIM21-dependent pathway (vol 8, pg 549, 2018)

A live attenuated virus-based intranasal COVID-19 vaccine provides rapid, prolonged, and broad protection against SARS-CoV-2

Baseline Quantitative Hepatitis B Core Antibody Titer Is a Predictor for Hepatitis B Virus Infection Recurrence After Orthotopic Liver Transplantation

Cross-neutralizing antibodies bind a SARS-CoV-2 cryptic site and resist circulating variants

Efficient intracellular delivery of proteins by a multifunctional chimaeric peptide in vitro and in vivo

A recombinant spike protein subunit vaccine confers protective immunity against SARS-CoV-2 infection and transmission in hamsters

Lost Small Envelope Protein Expression from Naturally Occurring PreS1 Deletion Mutants of Hepatitis B Virus Is Often Accompanied by Increased HBx and Core Protein Expression as Well as Genome Replication

Role of Small Envelope Protein in Sustaining the Intracellular and Extracellular Levels of Hepatitis B Virus Large and Middle Envelope Proteins

SAMD4 family members suppress human hepatitis B virus by directly binding to the Smaug recognition region of viral RNA

Gender associates with both susceptibility to infection and pathogenesis of SARS-CoV-2 in Syrian hamster

Replication, pathogenicity, and transmission of SARS-CoV-2 in minks

Naturally occurring 5' preS1 deletions markedly enhance replication and infectivity of HBV genotype B and genotype C

Several FDA-Approved Drugs Effectively Inhibit SARS-CoV-2 Infection in vitro

Virus-Free and Live-Cell Visualizing SARS-CoV-2 Cell Entry for Studies of Neutralizing Antibodies and Compound Inhibitors

Preparation and functional evaluation of monoclonal antibodies targeting Hepatitis B Virus Polymerase

Specific determination of hepatitis B e antigen by antibodies targeting precore unique epitope facilitates clinical diagnosis and drug evaluation against hepatitis B virus infection

A SCID mouse-human lung xenograft model of SARS-CoV-2 infection

Antibody Responses to SARS-CoV-2 in Patients With Novel Coronavirus Disease 2019

Expression Level of Small Envelope Protein in Addition to Sequence Divergence inside Its Major Hydrophilic Region Contributes to More Efficient Surface Antigen Secretion by Hepatitis B Virus Subgenotype D2 than Subgenotype A2

Serology characteristics of SARS-CoV-2 infection after exposure and post-symptom onset

Structure guided maturation of a novel humanized anti-HBV antibody and its preclinical development

Quantatitative assays for covalently closed circular DNA of hepatitis B virus

A unique B cell epitope-based particulate vaccine shows effective suppression of hepatitis B surface antigen in mice

Tumor-targeting oncolytic virus elicits potent immunotherapeutic vaccine responses to tumor antigens

SARS-CoV-2 spike produced in insect cells elicits high neutralization titres in non-human primates

Robust neutralization assay based on SARS-CoV-2 S-protein-bearing vesicular stomatitis virus (VSV) pseudovirus and ACE2-overexpressing BHK21 cells

Nanobody-based sandwich reporter system for living cell sensing influenza A virus infection

HBV infection-induced liver cirrhosis development in dual-humanised mice with human bone mesenchymal stem cell transplantation

Agonist c-Met monoclonal antibody augments the proliferation of hiPSC-derived hepatocyte-like cells and improves cell transplantation therapy for liver failure in mice

Simultaneous in situ visualization and quantitation of dual antigens adsorbed on adjuvants using high content analysis

Structural and functional analyses of hepatitis B virus X protein BH3-like domain and Bcl-xL interaction

Association Between High Levels of Hepatitis B Core Antibody and Seroclearance of Hepatitis B e Antigen in Individuals With Chronic Hepatitis B Virus Infection

Robust in vitro assay for analyzing the neutralization activity of serum specimens against hepatitis B virus

Structure and function analysis of the C-elegans aminophospholipid translocase TAT-1

Level of Hepatitis B (HB) Core Antibody Associates With Seroclearance of HBV DNA and HB Surface Antigen in HB e Antigen-Seronegative Patients

Agonist c-Met Monoclonal Antibody Augments the Proliferation of hiPSC-derived Hepatocyte-Like Cells and Improves Cell Transplantation Therapy for Liver Failure in Mice

Optimized HepaRG is a suitable cell source to generate the human liver chimeric mouse model for the chronic hepatitis B virus infection

Quantification of HBV core antibodies may help predict HBV reactivation in patients with lymphoma and resolved HBV infection

ER stress regulating protein phosphatase 2A-B56 gamma, targeted by hepatitis B virus X protein, induces cell cycle arrest and apoptosis of hepatocytes

A Chimeric Humanized Mouse Model by Engrafting the Human Induced Pluripotent Stem Cell-Derived Hepatocyte-Like Cell for the Chronic Hepatitis B Virus Infection

A novel noninvasive index for the prediction of moderate to severe fibrosis in chronic hepatitis B patients

Lower baseline quantitative HBcAb may help predict response to sequential combination therapy with IFN, rhIL-2 and HBV therapeutic vaccine in entecavir-suppressed CHB patients

Role of quantitative hepatitis B core antibody levels in predicting significant liver inflammation in chronic hepatitis B patients with normal or near-normal alanine aminotransferase levels

A novel therapeutic anti-HBV antibody with increased binding to human FcRn improves in vivo PK in mice and monkeys

A cell-penetrating whole molecule antibody targeting intracellular HBx suppresses hepatitis B virus via TRIM21-dependent pathway

Bioinspired Artificial Nanodecoys for Hepatitis B Virus

The unique antibody suppresses HBV viremia and reduces hepatocarcinogenesis in HBV-transgenic mice

Long-term outcome of inactive and active, low viraemic HBeAg-negative-hepatitis B virus infection: Benign course towards HBsAg clearance

A multimechanistic antibody targeting the receptor binding site potently cross-protects against influenza B viruses

Detection of HBV Covalently Closed Circular DNA

Low viremic HBeAg negative HBsAg carriers: Clinical outcome and non invasive diagnostic accuracy for chronic hepatitis B or inactive infection by combinations of HBV markers

Baseline hepatitis B core antibody predicts treatment response in chronic hepatitis B patients receiving long-term entecavir

A novel toolbox for the in vitro assay of hepatitis D virus infection

Low viremic HBeAg negative HBsAg carriers: clinical outcome and non invasive diagnostic accuracy for chronic hepatitis B or inactive infection by combinations of HBV markers

The gRNA-miRNA-gRNA Ternary Cassette Combining CRISPR/Cas9 with RNAi Approach Strongly Inhibits Hepatitis B Virus Replication

Antibody-mediated immunotherapy against chronic hepatitis B virus infection

Increasing the Efficiency of CRISPR/Cas9-mediated Precise Genome Editing of HSV-1 Virus in Human Cells

Serum hepatitis B virus RNA is encapsidated pregenome RNA that may be associated with persistence of viral infection and rebound

Baseline Quantitative Hepatitis B Core Antibody Level strongly Predicts 240-week Treatment Response in HBeAg-positive Chronic Hepatitis B Patients Receiving Entecavir

Functional characterization of hepatitis B virus core promoter mutants revealed transcriptional interference among co-terminal viral mRNAs

An HBV-tolerant immunocompetent model that effectively simulates chronic hepatitis B virus infection in mice

Pharmacological targeting of kinases MST1 and MST2 augments tissue repair and regeneration

Sleeping Beauty transposon-based system for rapid generation of HBV-replicating stable cell lines

A fast and low-cost genotyping method for hepatitis B virus based on pattern recognition in point-of-care settings

Prolonged suppression of HBV in mice by a novel antibody that targets a unique epitope on hepatitis B surface antigen

Detection and analysis of tupaia hepatocytes via mAbs against tupaia serum albumin

Development of an HSV-1 neutralization test with a glycoprotein D specific antibody for measurement of neutralizing antibody titer in human sera

Evaluation of a novel chemiluminescent microplate enzyme immunoassay for hepatitis B surface antigen detection

Baseline quantitative hepatitis B core antibody titre alone strongly predicts HBeAg seroconversion across chronic hepatitis B patients treated with peginterferon or nucleos(t)ide analogues

Total Hepatitis B Core Antigen Antibody, a Quantitative Non-Invasive Marker of Hepatitis B Virus Induced Liver Disease

Rapid fluorescent lateral-flow immunoassay for hepatitis B virus genotyping

Ground-glass hepatocytes co-expressing hepatitis B virus X protein and surface antigens exhibit enhanced oncogenic effects and tumorigenesis

Toward the development of monoclonal antibody-based assays to probe virion-like epitopes in hepatitis B vaccine antigen

HBV life cycle is restricted in mouse hepatocytes expressing human NTCP

Quantitative hepatitis B core antibody level may help predict treatment response in chronic hepatitis B patients

Baseline Quantitative Hepatitis B Core antibody is the Strongest Predictor for 2-year HBeAg seroconversion in HBeAg Positive CHB Patients Treated with Telbivudine Alone or Combined with Adefovir

Serum miR-483-5p as a potential biomarker to detect hepatocellular carcinoma

Performance evaluation of three different immunoassays for detection of antibodies to hepatitis B core

Hepatitis B Virus Surface Antigen (HBsAg)-Positive and HBsAg-Negative Hepatitis B Virus Infection among Mother-Teenager Pairs 13 Years after Neonatal Hepatitis B Virus Vaccination

Hepatitis B virus X protein targets Bcl-2 proteins to increase intracellular calcium, required for virus replication and cell death induction

Influence of mutations in hepatitis B virus surface protein on viral antigenicity and phenotype in occult HBV strains from blood donors

Estrogen Receptor alpha Represses Transcription of HBV Genes via Interaction With Hepatocyte Nuclear Factor 4 alpha

TYPE II GROUND GLASS HEPATOCYTES CO-EXPRESS HBSAG AND HBX PROTEINS AND REPRESENT PRENEOPLASTIC LESIONS

Differential diagnosis of pandemic (H1N1) 2009 infection by detection of haemagglutinin with an enzyme-linked immunoassay

Molecular and Phylogenetic Analyses Suggest an Additional Hepatitis B Virus Genotype

Clinical Significance of Anti-HEV IgA in Diagnosis of Acute Genotype 4 Hepatitis E Virus Infection Negative for Anti-HEV IgM